The Why
The benefits of quitting smoking are significant as the functioning of every major bodily system improves and the risk of many smoking-related illnesses declines. Smoking cessation clinical research is finding a combination drug therapies and behavioral strategies are helping more people become former smokers.
While NRT, varenicline, and sustained-release bupropion are regarded as first-choice therapies for smoking cessation, HRHR is testing promising new solutions for smoking cessation.